scorecard

You Searched For "vaccine trials" and got 20 results


Sort By:


Business Insider Latest Story Image
2 mins read

Covaxin shows 77.8% effectiveness against symptomatic COVID-19 cases in phase-3 trials

The efficacy analysis demonstrates Covaxin to be 93.4 per cent effective against severe symptoma…

PTI   


Business Insider Latest Story Image
1 min read

DGCI allows Serum Institute to export malaria vaccine to UK

The Drugs Controller General of India (DCGI) has granted permission to send two lakh doses of th…

PTI   


Business Insider Latest Story Image
1 min read

Another Chinese Covid-19 vaccine enters late-stage human trials with a plan to produce 300 million doses annually

Chinese vaccine maker Anhui Zhifei Longcom Biopharmaceutical Co., Ltd. has commenced the phase-3 cl…

Business Insider Latest Story Image
2 mins read

Schools received threatening letters from ant-vaxxers warning teachers they would face 'Nuremberg-style trials'

A report found that 79% of schools in England have received threatening emails from anti-vaxxers. T…

Alia Shoaib   


Business Insider Latest Story Image
2 mins read

The fourth largest phase 3 COVID-19 vaccine trial has started enrolling volunteers

Up to 60,000 volunteers will be enrolled in the trial at up to nearly 215 clinical research si…

Business Insider Latest Story Image
3 mins read

India’s homegrown cervical cancer vaccine can be a game changer say doctors

As per World Health Organization estimates, India has around one-fifth of the global cervical cance…

Business Insider Latest Story Image
2 mins read

Oxford COVID-19 vaccine: SII pauses trials in India following show-cause notice

"We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. W…

Business Insider Latest Story Image
2 mins read

Canada has enough COVID-19 vaccine doses to cover each citizen five times over while the fate of 67 poor countries remains undecided

As the pharmaceutical companies around the world are locked in a race to develop a vaccine for the …

Business Insider Latest Story Image
4 mins read

Vaccines for RSV, the illness that's been sickening babies across the US, are poised to become available in 2023

Scientists were 'afraid' to develop an RSV vaccine after one trialed in the '60s made kids sicker. …

Hilary Brueck   


Business Insider Latest Story Image
2 mins read

Pfizer-BioNTech COVID-19 vaccine shows 100% efficacy in 12-15 yrs old

"We share the urgency to expand the authorisation of our vaccine to use in younger populations…

Business Insider Latest Story Image
3 mins read

I'm an immunologist. Here's why I enrolled my baby and toddler in Pfizer's COVID-19 vaccine trial.

An immunologist shares her experience with having her children in the Pfizer COVID-19 vaccine trial.

Jamie Orsini   


Business Insider Latest Story Image
2 mins read

Twin 9-year-old girls received a Pfizer shot, becoming the first participants in a COVID-19 vaccine trial for children under 12

Pfizer joins Moderna and AstraZeneca in testing the COVID-19 shot in kids. The company will test 14…

Kelsie Sandoval   


Business Insider Latest Story Image
2 mins read

Expert panel of India's drug regulator mulling Bharat Biotech's nasal vaccine trial proposal

A meeting of the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation …

Business Insider Latest Story Image
1 min read

Clinical trials indicate AstraZeneca protects against COVID-19, says America's National Institutes of Health

Results from a large clinical trial in the US and South America indicate that the AstraZeneca Covid…

Business Insider Latest Story Image
2 mins read

FDA authorizes Pfizer and Moderna COVID-19 vaccines for children as young as 6 months old

The vaccines will be available for young children once the CDC recommends them, which will likely h…

Jake Epstein,Hilary Brueck   


Business Insider Latest Story Image
2 mins read

Andrew Dunn   


Business Insider Latest Story Image
2 mins read

India's drug controller grants approval to Sanofi and Glaxo Smith Kline to conduct Phase-3 trials of their COVID-19 vaccine

The global, randomised, double-blind Phase-III study will include more than 35,000 volunteers ag…

Business Insider Latest Story Image
2 mins read

Phase-II trial of Russia's COVID-19 vaccine awaits DCGI nod in India

country, and out of them 75 will be administered the vaccine.

PTI   


Business Insider Latest Story Image
2 mins read

Vicky Ge Huang   


Business Insider Latest Story Image
2 mins read

AstraZeneca resumes COVID-19 trial in Japan but still keeps its US trial on pause

AstraZeneca said the trial resumed in Japan after consultation with the Japanese Pharmaceuticals an…

Saloni Sardana